Ischemic stroke(IS)causes severe disability and high mortality worldwide.Stem cell(SC)therapy exhibits unique therapeutic potential for IS that differs from current treatments.SC’s cell homing,differentiation and par...Ischemic stroke(IS)causes severe disability and high mortality worldwide.Stem cell(SC)therapy exhibits unique therapeutic potential for IS that differs from current treatments.SC’s cell homing,differentiation and paracrine abilities give hope for neuroprotection.Recent studies on SC modification have enhanced therapeutic effects for IS,including gene transfection,nanoparticle modification,biomaterial modification and pretreatment.Thesemethods improve survival rate,homing,neural differentiation,and paracrine abilities in ischemic areas.However,many problems must be resolved before SC therapy can be clinically applied.These issues include production quality and quantity,stability during transportation and storage,as well as usage regulations.Herein,we reviewed the brief pathogenesis of IS,the“multi-mechanism”advantages of SCs for treating IS,various SC modification methods,and SC therapy challenges.We aim to uncover the potential and overcome the challenges of using SCs for treating IS and convey innovative ideas for modifying SCs.展开更多
To the Editor:Axial spondyloarthritis(axSpA)is a chronic inflammatory disease.[1]The hallmark of ankylosing spondylitis(AS)phenotype is sacroiliac joint and spinal damage characterized by the new bone formation and jo...To the Editor:Axial spondyloarthritis(axSpA)is a chronic inflammatory disease.[1]The hallmark of ankylosing spondylitis(AS)phenotype is sacroiliac joint and spinal damage characterized by the new bone formation and joint fusion,which results in irreversible functional disability and reduced quality of life.展开更多
基金supported by the National Natural Science Foundation of China(U22A20383,82003668)the Natural Science Foundation of Zhejiang Province(LD22H300002,LQ21H300002)Ningbo Technology Innovation 2025 Major Special Project(2022Z150).
文摘Ischemic stroke(IS)causes severe disability and high mortality worldwide.Stem cell(SC)therapy exhibits unique therapeutic potential for IS that differs from current treatments.SC’s cell homing,differentiation and paracrine abilities give hope for neuroprotection.Recent studies on SC modification have enhanced therapeutic effects for IS,including gene transfection,nanoparticle modification,biomaterial modification and pretreatment.Thesemethods improve survival rate,homing,neural differentiation,and paracrine abilities in ischemic areas.However,many problems must be resolved before SC therapy can be clinically applied.These issues include production quality and quantity,stability during transportation and storage,as well as usage regulations.Herein,we reviewed the brief pathogenesis of IS,the“multi-mechanism”advantages of SCs for treating IS,various SC modification methods,and SC therapy challenges.We aim to uncover the potential and overcome the challenges of using SCs for treating IS and convey innovative ideas for modifying SCs.
基金supported by grants from the National Natural Science Foundation of China(Nos.81971532,81971533)the clinical research incubation program of Jiangsu Province Hospital.
文摘To the Editor:Axial spondyloarthritis(axSpA)is a chronic inflammatory disease.[1]The hallmark of ankylosing spondylitis(AS)phenotype is sacroiliac joint and spinal damage characterized by the new bone formation and joint fusion,which results in irreversible functional disability and reduced quality of life.
